Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Liarozole

EU orphan designation number: EU/3/03/144   
Active ingredient: Liarozole
Indication: Treatment of congenital ichthyoses
Sponsor: Stiefel Laboratories (U.K.) Limited
Eurasia Headquarters, Concord Road, Maidenhead, Berkshire SL6 4BY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/06/2003 Centralised Orphan - Designation EMEA/OD/073/02 (2003)1882 of 10/06/2003
08/06/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/073/02/T/01 (2010)3722 of 04/06/2010